Company: XERI
Filing Date: 2025-04-02
Form Type: 8-K
Source: 0001477932-25-002373
Chunk: 0

Company: XERIANT, INC.
Filing Date: 2025-04-02
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

.

Effective March 31, 2025, Edward DeFeudis resigned as a director of Xeriant, Inc. (the “ Company”). His resignation was not because of any disagreement with the Company or its management on any matter relating to the Company’s operations, policies or practices.

Effective March 31, 2025, Mark Sternberg was elected as a director of the Company. Mr. Sternberg had been serving as a member of the Company’s Board of Advisors since January 14, 2025 and his compensation arrangement as an advisor will extend to his role as a director. Mr. Sternberg was granted 1,000,000 shares of the Company’s common stock vesting on a quarterly basis; $2,500 per formal meeting paid in cash, shares of Common Stock, or a combination thereof; an additional $25,000 paid in shares of Common Stock at the end of each year of service, paid in shares; and additional compensation for business development, intellectual property development, patent development and government and industry partnerships in such amounts as determined by the other members of the Board of Directors. There is no arrangement or understanding between Mr. Sternberg and any other persons pursuant to which he was selected as a director.

Mr. Sternberg brings extensive knowledge and expertise in the design, development and manufacturing of functional nano-coatings, having served as the Chief Executive Officer of an industrial coatings company. Over the past thirty years, Mr. Sternberg has patented nanomaterial products and manufacturing techniques for a variety of applications, including building materials.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

                            XERIANT, INC.                                            
  Date: March 31, 2025      By:                /s/ KEITH DUFFY                       
                                               Keith Duffy, Chief Executive Officer  

   3